Pharmaceutical Industry Information Portal

HomeNews

News

The first Russian injectable drug for treatment of COVID-19 is ap-proved

The first Russian direct-acting intravenous antiviral drug Areplivir® (favipiravir) received marketing authorization certificate and its supply to hospitals in all regions will start by...

R-Pharm presented results of phase III global research program for rheumatoid arthritis drug, novel IL-6 inhibitor Olokizumab

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III...

R-Pharm presented results of phase III global research program – CREDO

In the framework of the annual ACR Convergence 2021, R-Pharm Group presented successful results of olokizumab in two randomized clinical trials of phase III global research program — CREDO (Clinical RhEumatoid Arthritis Development...

Haikou city opens Hainan’s first pharmaceutical equipment service base

Haikou city, the administrative center of Hainan, announced the opening of the island's first modern pharmaceutical equipment maintenance facility,  TASS reports with a reference...

Expert RA assigns an expected ruA credit rating to Binnopharm Group’s planned bond issue

Binnopharm Group, a holding company that combines Sistema’s pharmaceutical assets, announces that the Expert RA rating agency has assigned an expected ruA credit rating...

Revenue of PROMOMED DM LLC for 9 months of 2021 increased by 194.74% and amounted to RUB 13.25 bln.

PROMOMED DM LLC publishes financial statements for 9 months of 2021 compiled in accordance with Russian Accounting Standards (RAS). According to the results of 9...
spot_img

Expert Articles

spot_img